An interview with the editor of The Lancet where he explains those recent retractions. A story of an ecologic problem in the voice of Rudyard Kipling. A query into fishy meanings of a name.
At long last, the FDA approved biotech salmon, AquaAdvantage, which is bred to grow to twice the size of other fish. But in contrast to every scientific study and advisory, the editorial board of The New York Times writes that the genetically-modified fish should be labelled. We take issue with that position.